The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2

Thrombosis Research

Volumn 129, Issue 6, 2012, Pages 793-796

  MacHovec, Kelly A ^a   Ushakumari, Deepu S ^a   Welsby, Ian J ^b   Nielsen, Vance G ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon monoxide releasing molecule; Fibrinogen concentrate; Hemodilution; Thrombelastography

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; FIBRINOGEN CONCENTRATE; PROCOAGULANT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTALLOID; FEMALE; GROWTH RATE; HEMOSTASIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PURIFICATION; THROMBOELASTOGRAPHY; THROMBUS; VELOCITY;

ADULT; BLOOD COAGULATION; FEMALE; FIBRINOGEN; HEMODILUTION; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; THROMBELASTOGRAPHY; YOUNG ADULT;

EID: 84861334665     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.08.005     Document Type: Article

References (14)

1. C. Fenger-Eriksen, E. Anker-Moller, J. Heslop, J. Ingerslev, and B. Sorensen Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate Br J Anaesth 94 2005 324 329
2. D. Fries, P. Innerhofer, C. Reif, W. Streif, A. Klingler, and W. Schobersberger The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model Anesth Analg 102 2006 347 351
3. D. Fries, A. Krismer, A. Klingler, W. Streif, G. Klima, and V. Wenzel Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model Br J Anaesth 95 2005 172 177
4. C. Fenger-Erickson, M. Lindberg-Larsen, A.Q. Christensen, J. Ingerslev, and B. Sorensen Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations Br J Anaesth 101 2008 769 773
5. H.R. Thorarinsdottir, F.T. Sigurbjornsson, K. Hreinsson, P.T. Onundarson, T. Gudbjartsson, and G.H. Sigurdsson Effects of fibrinogen concentrate administration during severe hemorrhage Acta Anaesthesiol Scand 54 2010 1077 1082
6. C. Solomon, U. Pichlmaier, H. Schoechl, C. Hagl, K. Raymondos, and D. Scheinichen Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery Br J Anaesth 104 2010 555 562
7. M. Karlsson, L. Ternström, M. Hyllner, F. Baghaei, A. Flinck, and S. Skrtic Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery Thromb Haemost 102 2009 137 144
8. V.G. Nielsen, J.K. Kirklin, and J.F. George Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma Blood Coagul Fibrinolysis 20 2009 377 380
9. V.G. Nielsen, S.N. Malayaman, E.S. Khan, J.K. Kirklin, and J.F. George Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity Blood Coagul Fibrinolysis 21 2010 349 353
10. V.G. Nielsen, J.K. Kirklin, J.F. George, and J.D. Messinger Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and factor XIII deficient plasma Blood Coagul Fibrinolysis 21 2010 101 105
11. V.G. Nielsen, J.B. Cohen, S.N. Malayaman, M. Nowak, K. Vosseller. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report. Blood Coagul Fibrinolysis 2011;22:443-7.
12. V.G. Nielsen, J.K. Kirklin, and J.F. George Carbon monoxide releasing molecule-2 (CORM-2) decreases fibrinolysis in human plasma Blood Coagul Fibrinolysis 20 2009 448 455
13. E. Monzani, B. Bonafe, A. Fallarini, C. Redaelli, L. Casella, and L. Minchiotti Enzymatic properties of human hemalbumin Biochim Biophys Acta 1547 2001 302 312
14. V.G. Nielsen, W.Q. Gurley, and T.M. Burch The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography Anesth Analg 99 2004 120 123